Parker J, Sawtell R, Gagnon L, et al. PBI-4050 Is Safe and Well Tolerated and Shows Evidence of Benefit in Idiopathic Pulmonary Fibrosis. ATS 2017, A7606.
Risicobeoordeling bij medicamenteus behandelde CTEPH-patiënten
nov 2018 | Pulmonale hypertensie